NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the acquisition of 9.25648743 Bitcoin (“BTC”) for an aggregate purchase price of $1,005,000 (gross of fees), at an average acquisition price of $108,301.75 per BTC. Following this transaction, CDT’s total Bitcoin holdings now stand at 17.9090111 BTC. This acquisition marks a continued execution of CDT’s cryptocurrency treasury reserve strategy, aimed at divers ...

NAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced the strategic acquisition of 8.65252366 Bitcoin (“BTC”) for an aggregate purchase price of $1,000,000 (inclusive of fees and expenses), at an average acquisition price of $115,285 per BTC. By incorporating Bitcoin into its treasury reserve strategy, CDT aims to strengthen its financial position and reinforce balance sheet resilience, while aligning with the ac ...

Core Insights - Eyenovia has acquired a significant position in HYPE tokens, making it the first Nasdaq-listed company to operate a validator on the Hyperliquid blockchain [1][2] - The company has successfully closed a $50 million private placement (PIPE) to fund the acquisition of 1,040,584.5 HYPE tokens at an average price of approximately $34 per token [2][3] - Eyenovia is on track for FDA registration of its Optejet User Filled Device (UFD) by September 2025, with ongoing discussions for potential partnerships [1][5] Company Strategy - The acquisition of HYPE tokens is part of Eyenovia's new cryptocurrency treasury reserve strategy aimed at creating long-term shareholder value through digital currency adoption [3] - The company plans to initiate its own network validator to support the Hyperliquid blockchain and access HYPE staking yield [2][3] - Eyenovia is expected to change its name and ticker to "Hyperion DeFi" and "HYPD" pending Board approval [4] Product Development - Development of the Optejet UFD is progressing as planned, with verification and validation activities set to begin next month [5] - The Optejet is designed for various topical ophthalmic liquids, enhancing treatment compliance and outcomes for patients with chronic front-of-the-eye diseases [9] Hyperliquid Platform Overview - Hyperliquid is a layer one blockchain optimized for high-frequency trading, featuring on-chain perpetual futures and spot order books [6] - HYPE, the native token of Hyperliquid, provides utility through reduced trading fees and increased referral bonuses, with over 25 million HYPE sequestered by the blockchain as of June 2025 [7]